Immune-Related Fulminant Myocarditis in a Patient Receiving Ipilimumab Therapy for Relapsed Chronic Myelomonocytic Leukaemia
European Journal of Heart Failure - United States
doi 10.1002/ejhf.806
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2017
Authors
Publisher
Wiley